Ambrx Biopharma Inc. Increase (Decrease) in Deferred Revenue
Ambrx Biopharma Inc. reported Increase (Decrease) in Deferred Revenue of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-08-09
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for the quarter ending 2023-06-30 was $0.00.
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for the quarter ending 2023-03-31 was $0.00.
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for the quarter ending 2022-06-30 was -$509.00K.
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for the quarter ending 2022-03-31 was -$893.00K.
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for fiscal 2022 was -$3.90M.
- Ambrx Biopharma Inc. increase (decrease) in deferred revenue for fiscal 2021 was -$4.08M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | -$3.90M 10-K · filed 2023-03-30 | ||
| 2022-06-30 | -$509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.40M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | -$893.00K 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | -$4.08M 10-K · filed 2023-03-30 | ||
| 2021-06-30 | -$3.66M 6-K · filed 2022-08-29 | ||
| 2020-12-31 | -$1.28M 20-F · filed 2022-04-26 | ||
| 2019-12-31 | $11.01M 20-F · filed 2022-04-26 |